The Blog.
Retatrutide vs Tirzepatide: a practical comparison
Two GLP-1s, two pharmacokinetic profiles, two very different titration curves. Here's how we'd decide between them, based on what the trials actually show.
How to read a free testosterone trend line
Total T tells you almost nothing. Free T tells you most of the story. This is how to read the shape, not just the number.
Reconstitution math, without the anxiety
Most reconstitution errors are not math errors — they're attention errors. A two-step process that removes every chance for either.
GLP-1 plateau? Read your macros first
Nine times out of ten, a stalled GLP-1 protocol isn't a dose problem — it's a protein problem. Here's how to tell the difference.
BPC-157: what the literature actually says
Strip out the forum noise and you're left with a small, surprisingly consistent body of work. Here's our annotated summary.
Sleep, HRV, and why your stack stalls
The fastest way to predict whether your next titration will work isn't a biomarker — it's last week's HRV trend.
The case for monthly bloodwork
Quarterly was a print-era number. If you're titrating, monthly is the floor — and here's how to pay for it without going broke.
Cycling off: a quiet, underrated skill
Knowing how to stop a peptide cleanly is half the protocol. We rarely talk about it. We should.
Photo logging: why three angles beat the scale
The scale lags by 2–3 weeks. Photos don't. A short note on how we use them and what to discard.
Glucose awareness without a CGM
Not everyone wants a sensor stuck to their arm. Here's the next-best practice, with cited reference ranges.